Refine by
Diabetes Foot Articles & Analysis
35 news found
” Among the populations that may particularly benefit from these new treatments are: The elderly: 2–3% of whom have venous/arterial leg ulcers. People with diabetes: 25% of whom will suffer from potentially disabling diabetic foot ulcers (DFUs) during their lifetime. ...
Destiny Pharma is developing the novel formulation of XF-73 Dermal for the prevention of infections associated with open wounds and broken skin including diabetic foot ulcers (DFUs) – up to 25% of US diabetic patients may suffer from DFUs in their lifetime and c. 13% have active ulcers. ...
Pravibismane has also demonstrated safety in multiple clinical studies including treatment of patients with diabetic foot infections and patients with serious orthopedic device-related infections. ...
VisionQuest Biomedical founder and CEO Peter Soliz (PhD) has just been awarded a $1 million Commercialization Readiness Pilot Program (CRP) grant from the National Institute of Diabetes and Digestive and Kidney Diseases (part of the US National Institutes of Health) for his work on early detection of DPN. ...
The evaluation and treatment of diabetic foot ulcers and diabetic foot infections. Foot & Ankle Orthopaedics. 2018;3:3. doi:10.1177/2473011418788864 2.Sundararajan PP, Porter BM, Grant KA, et al. ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation advanced wound care medical systems for the repair and regeneration of skin and vascular structures and the research for new applications for shockwave systems in the non-medical field, announced today the patent activity for the full year 2020 and the first quarter of ...
Patented Large Area Shockwaves Technology (LAST) provides delivery of low intensity shockwaves - covering whole regions - for ED treatment as well as Wound Healing (Diabetic Foot Ulcers - DFU). Arm mounted applicators free Operator to engage in other tasks during six painless sessions for ED, or about twelve sessions for DFU, treatment of seated patients. ...
” In a previous multi-center trial, diabetic foot complications were shown to be detected up to five weeks before they presented clinically. ...
China has the world’s largest Diabetic and resultingly Diabetic Foot Ulcer (DFU) population. The International Diabetes Federation estimates that 10.6% of the Chinese adult population now have diabetes that equates to 141 million people. ...
We’re looking forward to presenting “Detecting Diabetic Peripheral Neuropathy Utilizing Thermoregulation of the Plantar Foot” at the upcoming 82nd Scientific Sessions of the American Diabetes Association. Our research aims to detect thermal (infrared) biomarkers of diabetic peripheral neuropathy on the feet of ...
This announcement comes as the company successfully completed an exclusive license and collaboration agreement with XBiome for the clinical development and commercialization of AUP-16 for Diabetic Foot Ulcer (DFU), other chronic wounds, and inflammatory diseases in Greater China. “Diabetic ulcers are the leading cause of non-traumatic ...
Décory occurs in parallel with the company successfully completing an exclusive license and collaboration agreement with XBiome, for the clinical development and commercialization of AUP-16, Aurealis investigational therapy for Diabetic Foot Ulcer (DFU), other chronic wounds, and inflammatory diseases, in greater China. ...
He is recognized as a Key Opinion Leader on the diabetic foot, lower extremity wound care, limb salvage, podiatric medicine, and surgery. ...
Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based microbiome drug development company, today announced that the two companies have entered into an exclusive license and collaboration agreement for the clinical development and commercialization of Aurealis investigational Diabetic ...
SOMERVILLE, Mass., January 18, 2022 — Podimetrics, a virtual care support company dedicated to preventing costly and deadly diabetic amputations, today announced results from its latest research, which compared the health of individuals during and after periods of diabetic foot ulceration — open sores or wounds on the ...
Ultimately, patients' quality of life is significantly improved by successful therapy, e.g. in case of diabetic foot or open leg. Viromed's involvement will significantly intensify and further strengthen the existing, very successful cooperation. ...
PHILADELPHIA and SOMERVILLE, Mass., October 26, 2021 — Independence Blue Cross (Independence) and Podimetrics, a virtual care management company dedicated to preventing diabetic amputations, today announced an agreement for Podimetrics to remotely monitor Independence fully insured commercial members who have diabetes and a history of a ...
AOTI participated both as a sponsor and exhibitor at these events that were conducted in a hybrid format, where attendance could be either in person, or virtually, to allow for the greatest clinician engagement, something that has now become standard during the ongoing COVID-19 pandemic. The prestigious Malvern Diabetic Foot Conference, the world’s longest ...
VA Innovation Ecosystem leader recognized for the Initiative to End Diabetic Limb Loss. SOMERVILLE, Mass., June 29, 2021 — Podimetrics, a virtual care management company dedicated to preventing costly and deadly diabetic amputations, congratulates Suzanne Shirley today on winning the Service to Citizen Award in recognition for her leadership and ...
Additionally, a high-quality paper published on April 19, 2021 in the journal Diabetic Medicine, entitled Topical oxygen therapy for diabetes-related foot ulcers: A systematic review and meta-analysis (https://onlinelibrary.wiley.com/doi/10.1111/dme.14585), from the team headed by Professor Golledge at the independent Queensland Research Centre ...